Top 2

To Expand Cardiopulmonary Pipeline Merck Acquires Verona Pharma For $10 Billion

ProKidney Scores Win With Cell Therapy Rilparencel For CKD Patients

MoonLake Sought Out For By Merck For $3 Billion To Add Sonelokimab To Arsenal, FT Reports

Amazing Survival Feat In Solid Tumors Achieved With Merus Petosemtamab

In Flight To Enact Strategic Alternatives, Tempest Cuts 80% of its Workforce

Scroll to Top